IL125915A - A method for classifying pixels into groups according to their spectrum using a number of wide-range filters and a device for this purpose - Google Patents
A method for classifying pixels into groups according to their spectrum using a number of wide-range filters and a device for this purposeInfo
- Publication number
- IL125915A IL125915A IL12591598A IL12591598A IL125915A IL 125915 A IL125915 A IL 125915A IL 12591598 A IL12591598 A IL 12591598A IL 12591598 A IL12591598 A IL 12591598A IL 125915 A IL125915 A IL 125915A
- Authority
- IL
- Israel
- Prior art keywords
- filters
- fluorophores
- wide
- emission
- pixels
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 146
- 238000000295 emission spectrum Methods 0.000 claims abstract description 44
- 238000004422 calculation algorithm Methods 0.000 claims abstract description 39
- 239000013598 vector Substances 0.000 claims abstract description 35
- 210000000349 chromosome Anatomy 0.000 claims description 226
- 230000005284 excitation Effects 0.000 claims description 136
- 238000001228 spectrum Methods 0.000 claims description 70
- 230000031864 metaphase Effects 0.000 claims description 35
- 238000000695 excitation spectrum Methods 0.000 claims description 33
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 102000004169 proteins and genes Human genes 0.000 claims description 21
- 239000004973 liquid crystal related substance Substances 0.000 claims description 11
- 238000000354 decomposition reaction Methods 0.000 claims description 8
- 230000003595 spectral effect Effects 0.000 description 80
- 239000000975 dye Substances 0.000 description 78
- 238000005259 measurement Methods 0.000 description 45
- 239000000523 sample Substances 0.000 description 39
- 238000013459 approach Methods 0.000 description 33
- 210000003917 human chromosome Anatomy 0.000 description 31
- 238000009396 hybridization Methods 0.000 description 28
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 27
- 238000004458 analytical method Methods 0.000 description 26
- 238000003384 imaging method Methods 0.000 description 26
- 208000031404 Chromosome Aberrations Diseases 0.000 description 24
- 239000012634 fragment Substances 0.000 description 24
- 238000002372 labelling Methods 0.000 description 23
- 206010028980 Neoplasm Diseases 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 19
- 231100000005 chromosome aberration Toxicity 0.000 description 19
- 239000007850 fluorescent dye Substances 0.000 description 19
- 230000003287 optical effect Effects 0.000 description 19
- 238000010422 painting Methods 0.000 description 19
- 230000002559 cytogenic effect Effects 0.000 description 18
- 230000005945 translocation Effects 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 239000003973 paint Substances 0.000 description 15
- 230000008901 benefit Effects 0.000 description 14
- 238000000701 chemical imaging Methods 0.000 description 14
- 230000005855 radiation Effects 0.000 description 14
- 238000001514 detection method Methods 0.000 description 12
- 230000002068 genetic effect Effects 0.000 description 12
- 238000000386 microscopy Methods 0.000 description 12
- 230000005540 biological transmission Effects 0.000 description 11
- 239000003086 colorant Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 9
- 238000002189 fluorescence spectrum Methods 0.000 description 9
- 238000011065 in-situ storage Methods 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 238000004088 simulation Methods 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 230000002759 chromosomal effect Effects 0.000 description 8
- 238000001317 epifluorescence microscopy Methods 0.000 description 8
- 238000000799 fluorescence microscopy Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000016507 interphase Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 8
- 239000003298 DNA probe Substances 0.000 description 7
- 208000026350 Inborn Genetic disease Diseases 0.000 description 7
- 208000037280 Trisomy Diseases 0.000 description 7
- 230000004075 alteration Effects 0.000 description 7
- 208000016361 genetic disease Diseases 0.000 description 7
- 238000004611 spectroscopical analysis Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000007901 in situ hybridization Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 230000005856 abnormality Effects 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 230000009395 genetic defect Effects 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 210000004940 nucleus Anatomy 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 238000012800 visualization Methods 0.000 description 5
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 201000010374 Down Syndrome Diseases 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 206010044688 Trisomy 21 Diseases 0.000 description 3
- 230000011855 chromosome organization Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 230000007023 DNA restriction-modification system Effects 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- 206010064912 Malignant transformation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
- 238000007635 classification algorithm Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000009223 counseling Methods 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000002308 embryonic cell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000007903 genomic in situ hybridization Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000036212 malign transformation Effects 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000021121 meiosis Effects 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000000399 optical microscopy Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000003793 prenatal diagnosis Methods 0.000 description 2
- 238000000513 principal component analysis Methods 0.000 description 2
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 2
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000011691 Burkitt lymphomas Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 206010061764 Chromosomal deletion Diseases 0.000 description 1
- 208000035970 Chromosome Breakpoints Diseases 0.000 description 1
- 208000031639 Chromosome Deletion Diseases 0.000 description 1
- 208000016718 Chromosome Inversion Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- 101100384865 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cot-1 gene Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 108091081400 Subtelomere Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000006098 acoustic absorber Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000007698 birth defect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000000339 bright-field microscopy Methods 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- CZPLANDPABRVHX-UHFFFAOYSA-N cascade blue Chemical compound C=1C2=CC=CC=C2C(NCC)=CC=1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 CZPLANDPABRVHX-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000004252 chorionic villi Anatomy 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000008711 chromosomal rearrangement Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000012757 fluorescence staining Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003426 interchromosomal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001531 micro-dissection Methods 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 238000011527 multiparameter analysis Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000004214 philadelphia chromosome Anatomy 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000000411 transmission spectrum Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B21/00—Microscopes
- G02B21/06—Means for illuminating specimens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
- G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/917,213 US5834203A (en) | 1997-08-25 | 1997-08-25 | Method for classification of pixels into groups according to their spectra using a plurality of wide band filters and hardwire therefore |
Publications (2)
Publication Number | Publication Date |
---|---|
IL125915A0 IL125915A0 (en) | 1999-04-11 |
IL125915A true IL125915A (en) | 2001-11-25 |
Family
ID=25438492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12591598A IL125915A (en) | 1997-08-25 | 1998-08-25 | A method for classifying pixels into groups according to their spectrum using a number of wide-range filters and a device for this purpose |
Country Status (6)
Country | Link |
---|---|
US (1) | US5834203A (fr) |
EP (2) | EP0899558B1 (fr) |
JP (1) | JP3130508B2 (fr) |
DE (2) | DE69809161T2 (fr) |
ES (1) | ES2186097T3 (fr) |
IL (1) | IL125915A (fr) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5936731A (en) * | 1991-02-22 | 1999-08-10 | Applied Spectral Imaging Ltd. | Method for simultaneous detection of multiple fluorophores for in situ hybridization and chromosome painting |
US6018587A (en) * | 1991-02-21 | 2000-01-25 | Applied Spectral Imaging Ltd. | Method for remote sensing analysis be decorrelation statistical analysis and hardware therefor |
US6690817B1 (en) * | 1993-08-18 | 2004-02-10 | Applied Spectral Imaging Ltd. | Spectral bio-imaging data for cell classification using internal reference |
US6165734A (en) * | 1995-12-12 | 2000-12-26 | Applied Spectral Imaging Ltd. | In-situ method of analyzing cells |
US7498164B2 (en) | 1998-05-16 | 2009-03-03 | Applied Biosystems, Llc | Instrument for monitoring nucleic acid sequence amplification reaction |
CN1664562A (zh) | 1998-05-16 | 2005-09-07 | 阿普尔拉公司 | 用于监测dna聚合酶链反应的仪器 |
US6818437B1 (en) * | 1998-05-16 | 2004-11-16 | Applera Corporation | Instrument for monitoring polymerase chain reaction of DNA |
US6642062B2 (en) | 1998-09-03 | 2003-11-04 | Trellis Bioinformatics, Inc. | Multihued labels |
US6453060B1 (en) * | 1999-06-29 | 2002-09-17 | Tri Path Imaging, Inc. | Method and apparatus for deriving separate images from multiple chromogens in a branched image analysis system |
EP1269162A4 (fr) * | 2000-02-25 | 2005-01-19 | Cambridge Res & Instrmnt Inc | Systeme et procede de dosage par polarisation de la fluorescence de plusieurs marqueurs |
US6627748B1 (en) | 2000-09-11 | 2003-09-30 | The Trustees Of Columbia University In The City Of New York | Combinatorial fluorescence energy transfer tags and their applications for multiplex genetic analyses |
US20060057565A1 (en) * | 2000-09-11 | 2006-03-16 | Jingyue Ju | Combinatorial fluorescence energy transfer tags and uses thereof |
WO2002022883A1 (fr) * | 2000-09-11 | 2002-03-21 | The Trustees Of Columbia University In The City Of New York | Indicateurs de transfert d'energie de fluorescence combinatoire et utilisations associees |
ATE356222T1 (de) | 2000-10-06 | 2007-03-15 | Univ Columbia | Massives parallelverfahren zur dekodierung von dna und rna |
US9708358B2 (en) | 2000-10-06 | 2017-07-18 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
US20100279341A1 (en) * | 2000-10-24 | 2010-11-04 | Tissuegnostics Gmbh | Methods and system for analyzing cells |
AT411066B (de) * | 2000-10-24 | 2003-09-25 | Steiner Georg E | Verfahren und anordnung zur untersuchung von zellen |
DE10151217B4 (de) * | 2001-10-16 | 2012-05-16 | Carl Zeiss Microlmaging Gmbh | Verfahren zum Betrieb eines Laser-Scanning-Mikroskops |
DE10206979A1 (de) * | 2002-02-20 | 2003-08-21 | Leica Microsystems | Verfahren zum Benutzertraining für ein Scanmikroskop, Scanmikroskop und Software zum Benutzertraining für ein Scanmikroskop |
US7074597B2 (en) * | 2002-07-12 | 2006-07-11 | The Trustees Of Columbia University In The City Of New York | Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry |
AU2003273668A1 (en) * | 2002-10-02 | 2004-04-23 | Ifire Technology Corp.Lumen Health Innovations, Inc. | Apparatus and methods relating to high speed spectroscopy and excitation-emission matrices |
US20050032081A1 (en) * | 2002-12-13 | 2005-02-10 | Jingyue Ju | Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry |
US7321791B2 (en) * | 2003-09-23 | 2008-01-22 | Cambridge Research And Instrumentation, Inc. | Spectral imaging of deep tissue |
US8634607B2 (en) | 2003-09-23 | 2014-01-21 | Cambridge Research & Instrumentation, Inc. | Spectral imaging of biological samples |
US7315371B2 (en) * | 2004-01-23 | 2008-01-01 | P&P Optica Inc. | Multi-channel spectrum analyzer |
US7622279B2 (en) | 2004-03-03 | 2009-11-24 | The Trustees Of Columbia University In The City Of New York | Photocleavable fluorescent nucleotides for DNA sequencing on chip constructed by site-specific coupling chemistry |
EP1846869B1 (fr) | 2005-01-27 | 2011-10-05 | Cambridge Research & Instrumentation, Inc. | Classification de caracteristiques d'images |
DE102005022880B4 (de) * | 2005-05-18 | 2010-12-30 | Olympus Soft Imaging Solutions Gmbh | Trennung spektral oder farblich überlagerter Bildbeiträge in einem Mehrfarbbild, insbesondere in transmissionsmikroskopischen Mehrfarbbildern |
WO2007002204A2 (fr) | 2005-06-21 | 2007-01-04 | The Trustees Of Columbia University In The City Of New York | Procedes de pyrosequencage et compositions associees |
JP2007010340A (ja) | 2005-06-28 | 2007-01-18 | Olympus Corp | カメラ装置 |
DE102006052542B4 (de) * | 2006-11-06 | 2008-08-14 | Hochschule für angewandte Wissenschaft und Kunst (HAWK) Hildesheim | Bilderfassungseinrichtung |
US7883869B2 (en) | 2006-12-01 | 2011-02-08 | The Trustees Of Columbia University In The City Of New York | Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
DE102007014413B4 (de) * | 2007-03-17 | 2016-02-04 | DüRR DENTAL AG | Verfahren zum Auswerten von Fluoreszenzbildsätzen und Vorrichtung zu seiner Durchführung |
US8330087B2 (en) * | 2007-10-16 | 2012-12-11 | Cambridge Research & Instrumentation, Inc. | Spectral imaging system with dynamic optical correction |
US20110014611A1 (en) | 2007-10-19 | 2011-01-20 | Jingyue Ju | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis |
US9115163B2 (en) | 2007-10-19 | 2015-08-25 | The Trustees Of Columbia University In The City Of New York | DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
DE102008034008B4 (de) | 2008-07-21 | 2010-07-01 | Carl Zeiss Surgical Gmbh | Filtersatz zur Beobachtung von Fluoreszenzstrahlung in biologischem Gewebe |
US7969568B2 (en) * | 2008-10-24 | 2011-06-28 | Applied Materials, Inc. | Spectrographic metrology of patterned wafers |
US8774488B2 (en) | 2010-03-11 | 2014-07-08 | Cellscape Corporation | Method and device for identification of nucleated red blood cells from a maternal blood sample |
JP5494351B2 (ja) * | 2010-08-24 | 2014-05-14 | ソニー株式会社 | 蛍光強度補正方法、蛍光強度算出方法及び蛍光強度算出装置並びに蛍光強度補正プログラム |
US9624539B2 (en) | 2011-05-23 | 2017-04-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using Raman and infrared spectroscopy detection |
US8682047B2 (en) * | 2011-12-05 | 2014-03-25 | Illinois Tool Works Inc. | Method and apparatus for machine vision counting and annotation |
CN104271767B (zh) | 2012-02-03 | 2017-08-25 | 加州理工学院 | 多路生化测定中信号的编码和解码 |
US9791372B2 (en) * | 2012-08-03 | 2017-10-17 | California Institute Of Technology | Multiplexing and quantification in PCR with reduced hardware and requirements |
WO2014144883A1 (fr) | 2013-03-15 | 2014-09-18 | The Trustees Of Columbia University In The City Of New York | Molecules marquees par des amas de raman destinees a l'imagerie biologique |
EP3329209B1 (fr) * | 2015-07-30 | 2022-11-09 | Technology Innovation Momentum Fund (Israel) Limited Partnership | Procédé et système d'imagerie spectrale |
EP3251578A1 (fr) * | 2016-05-30 | 2017-12-06 | Leica Instruments (Singapore) Pte. Ltd. | Dispositif médical pour l'observation d'un objet partiellement fluorescent, à l'aide d'un système de filtre avec une fenêtre de transmission |
US10724958B2 (en) * | 2017-11-06 | 2020-07-28 | Senors Unlimited, Inc. | Imaging devices, imaging arrangements, and imaging methods |
JP7098146B2 (ja) * | 2018-07-05 | 2022-07-11 | 株式会社Iddk | 顕微観察装置、蛍光検出器及び顕微観察方法 |
DE102019101773B9 (de) * | 2019-01-24 | 2021-11-25 | Carl Zeiss Meditec Ag | Mikroskopiesystem und Verfahren zum Betreiben eines Mikroskopiesystems |
US11143587B2 (en) * | 2019-04-02 | 2021-10-12 | Becton, Dickinson And Company | Compensation editor |
WO2021127019A1 (fr) * | 2019-12-17 | 2021-06-24 | Applied Materials, Inc. | Système et procédé d'acquisition et de traitement d'images d'hybridation in-situ de fluorescence multiplexées |
JP7543824B2 (ja) * | 2020-10-09 | 2024-09-03 | セイコーエプソン株式会社 | 画像解析装置、画像解析方法、及び画像解析プログラム |
WO2022149744A1 (fr) * | 2021-01-05 | 2022-07-14 | 한국과학기술원 | Procédé et dispositif de séparation de couleurs multiples par minimisation de quantité d'informations mutuelles répétitives concernant une structure de mise à jour de canal simultanée |
EP4341670A1 (fr) * | 2021-05-19 | 2024-03-27 | Leica Microsystems CMS GmbH | Procédé et dispositif d'analyse d'un échantillon biologique |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994001968A1 (fr) * | 1992-07-08 | 1994-01-20 | Oncor, Inc. | Systeme de prise d'images couleur a faible niveau de lumiere, utilisant un appareil photographique integrateur a refroidissement |
US5556764A (en) * | 1993-02-17 | 1996-09-17 | Biometric Imaging, Inc. | Method and apparatus for cell counting and cell classification |
US5863504A (en) * | 1995-03-16 | 1999-01-26 | Bio-Rad Laboratories, Inc. | Fluorescence imaging instrument utilizing fish |
EP0879297A4 (fr) * | 1995-12-22 | 2003-04-16 | Biorad Lab Inc | Procede permettant de mener un hybridation in situ par fluorescence a parametres multiples et appareil correspondant |
-
1997
- 1997-08-25 US US08/917,213 patent/US5834203A/en not_active Expired - Lifetime
-
1998
- 1998-08-24 EP EP98306743A patent/EP0899558B1/fr not_active Revoked
- 1998-08-24 DE DE69809161T patent/DE69809161T2/de not_active Revoked
- 1998-08-24 ES ES98306743T patent/ES2186097T3/es not_active Expired - Lifetime
- 1998-08-24 EP EP02001413A patent/EP1207376A1/fr not_active Withdrawn
- 1998-08-24 DE DE29824467U patent/DE29824467U1/de not_active Expired - Lifetime
- 1998-08-25 IL IL12591598A patent/IL125915A/en not_active IP Right Cessation
- 1998-08-25 JP JP10279276A patent/JP3130508B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0899558A2 (fr) | 1999-03-03 |
US5834203A (en) | 1998-11-10 |
IL125915A0 (en) | 1999-04-11 |
DE69809161D1 (de) | 2002-12-12 |
JP3130508B2 (ja) | 2001-01-31 |
ES2186097T3 (es) | 2003-05-01 |
EP1207376A1 (fr) | 2002-05-22 |
DE69809161T2 (de) | 2003-03-20 |
EP0899558A3 (fr) | 1999-09-29 |
DE29824467U1 (de) | 2001-03-29 |
EP0899558B1 (fr) | 2002-11-06 |
JPH11166893A (ja) | 1999-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0899558B1 (fr) | Procédé et appareil de classification de pixels en groupes selon leurs spectres au moyen d'une pluralité de filtres à large bande | |
US5798262A (en) | Method for chromosomes classification | |
EP0896631B1 (fr) | Procede de detection simultanee de fluophores multiples pour l'hybridation in situ | |
JP3474579B2 (ja) | スペクトル生体結像方法および蛍光dnaハイブリダイゼーション方法 | |
EP0935679B1 (fr) | Procede de classification des chromosomes par analyse statistique de decorrelation et materiel associe | |
US5912165A (en) | Method for chromosome classification by decorrelaiton statistical analysis and hardware therefore | |
EP1100965A1 (fr) | Procede et composite d'hybridation fluorescente in situ | |
DE29624210U1 (de) | Vorrichtung zum gleichzeitigen Nachweis von multiplen Fluorophoren bei in situ Hybridisierung und Chromosomenanfärbung | |
US5871932A (en) | Method of and composite for fluorescent in situ hybridization | |
DE29724412U1 (de) | Vorrichtung zum gleichzeitgen Nachweis mehrerer Fluorophore für die in situ Hybridisierung | |
Breneman et al. | Automated spectral imaging for clinical diagnostics | |
DE29824468U1 (de) | Vorrichtung zur Chromosomen-Klassifizierung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |